Identification of small molecule inhibitors of USP15
USP15小分子抑制剂的鉴定
基本信息
- 批准号:10269707
- 负责人:
- 金额:$ 18.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Biological AssayBiological ProcessDevelopmentDiseaseEukaryotaExcisionFamilyGenesGlioblastomaHumanInflammatoryKnockout MiceLeadMachine LearningMalignant NeoplasmsMalignant neoplasm of ovaryNF-kappa BNeurodegenerative DisordersPathway interactionsPlayPost-Translational Protein ProcessingProteinsRoleSignal PathwayStructureT-Cell ActivationTP53 geneTestingTransforming Growth Factor betaUbiquitinUbiquitinationVirus DiseasesWorkbasebeta catenincancer immunotherapycancer typecolon cancer cell linehigh throughput screeninghuman diseasein silicoinhibitor/antagonistinterestmalignant breast neoplasmmelanomamouse modeloverexpressionprospectivescreeningsmall moleculesmall molecule inhibitortumorigenesisubiquitin-specific protease
项目摘要
Given USP15s role in tumorigenesis and T cell activation, USP15 is a promising target for cancer and cancer immunotherapy. Identification of USP15-specific small-molecule inhibitors through a quantitative high-throughput screening and further development of the lead compound could not only open new strategies to tackle cancer, but allow to better understand biological functions of USP15. During this period, the project team worked to validate small molecule hits from the previously completed high-throughput screen. Using activity profiles from the orthogonal assays tested against the screening hits, the team employed a machine learning approach to conduct an in silico screen against an additional 100,000 small molecules to extend the number of prospective chemotypes with inhibitory activity against USP15.
鉴于USP15在肿瘤发生和T细胞活化中的作用,USP15是癌症和癌症免疫治疗的一个有希望的靶点。通过定量高通量筛选鉴定USP15特异性小分子抑制剂,并进一步开发先导化合物,不仅可以开辟新的癌症治疗策略,而且可以更好地了解USP15的生物学功能。在此期间,项目团队致力于验证先前完成的高通量筛选中的小分子命中。利用正交试验对筛选结果的活性谱,研究小组采用机器学习方法对另外10万个小分子进行了硅筛选,以扩大对USP15具有抑制活性的潜在化学型的数量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anton Simeonov其他文献
Anton Simeonov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anton Simeonov', 18)}}的其他基金
PRKACA for Fibrolamellar hepatocellular carcinoma
PRKACA 治疗纤维板层肝细胞癌
- 批准号:
9554490 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
MST/ITC studies on Vimentin DHA interaction
MST/ITC 关于 Vimentin DHA 相互作用的研究
- 批准号:
9554499 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
Disrupting Type IV secretion function to prevent virulence in the pathogenic bacterium Legionella pneumophila
破坏 IV 型分泌功能以防止致病菌嗜肺军团菌的毒力
- 批准号:
9554502 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
High-throughput multiparametric drug screening method for 3D spheroids
3D球体高通量多参数药物筛选方法
- 批准号:
9554522 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
Identification of Grb10:Insulin Receptor Disruptors
Grb10:胰岛素受体干扰物的鉴定
- 批准号:
9554524 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
A Novel Compound for Targeted Treatment of CBF Leukemia
一种靶向治疗 CBF 白血病的新型化合物
- 批准号:
9354952 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
A Novel Compound for Targeted Treatment of CBF Leukemia
一种靶向治疗 CBF 白血病的新型化合物
- 批准号:
9205569 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
A Novel Compound for Targeted Treatment of CBF Leukemia
一种靶向治疗 CBF 白血病的新型化合物
- 批准号:
9550575 - 财政年份:
- 资助金额:
$ 18.66万 - 项目类别:
相似海外基金
Nitrous Oxide Management in a Novel Biological Process
新型生物过程中的一氧化二氮管理
- 批准号:
2789227 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Studentship
Dynamic regulation of RNA modification and biological process
RNA修饰和生物过程的动态调控
- 批准号:
18H05272 - 财政年份:2018
- 资助金额:
$ 18.66万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2017
- 资助金额:
$ 18.66万 - 项目类别:
Discovery Grants Program - Individual
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2016
- 资助金额:
$ 18.66万 - 项目类别:
Discovery Grants Program - Individual
Organizing the Waterloo Biofilter biological process for treating wastewater concentrated by extreme water conservation plumbing
组织滑铁卢生物过滤器生物工艺处理通过极端节水管道浓缩的废水
- 批准号:
479764-2015 - 财政年份:2015
- 资助金额:
$ 18.66万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2015
- 资助金额:
$ 18.66万 - 项目类别:
Discovery Grants Program - Individual
Development of Biological Process for VOC treatment
VOC处理生物工艺的开发
- 批准号:
476672-2014 - 财政年份:2015
- 资助金额:
$ 18.66万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2014
- 资助金额:
$ 18.66万 - 项目类别:
Discovery Grants Program - Individual
Optimization of a biological process treating winery wastewater: anaerobic digestion integrated with Waterloo biofilter
处理酿酒厂废水的生物工艺优化:厌氧消化与滑铁卢生物过滤器集成
- 批准号:
463193-2014 - 财政年份:2014
- 资助金额:
$ 18.66万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2013
- 资助金额:
$ 18.66万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




